Bad news for our athletic stimulant users down under!
On May 17, 2017, the Australian Government’s Department of Health posted a new advisory that recommends the ban of both DMHA and DMBA (AMP Citrate) effective October 1, 2017:
This is not yet set in stone, but historically, once the ban-ball gets rolling, they’re rarely ever stopped without a serious legal battle.
This advisory details the updated scheduling status of banned stimulants. Alongside DMAA, which is already a schedule 10 banned stimulant in Australia, AMP Citrate and DMHA were not yet scheduled. That all changes when they’ll get added to the Schedule 10 list alongside.
There is not a single reason provided — health or otherwise — why Australia is banning DMHA.
(Note that DMAA is still not banned in the US, as Hi-Tech Pharma is suing the FDA to use DMAA legally in supplements, as the stimulant has been found in geraniums numerous times.)
Either way, Australian fans most likely have until the end of September to stock up on their favorite legal stimulant, unless someone were to mount a major legal effort such as how Hi-Tech is battling the FDA in the states.
What’s next for Australia?
We’re not so sure what will happen next in Australia, but this pre-release video review of a mysterious new “Red Pill” may provide a hint:
Until then, read all there is to know about DMHA on PricePlow.
Thrown under the bus
Given that it’s been sold for two years and we’ve heard of zero adverse events, we’re inclined to say it’s a safe stimulant when used at the doses provided in these products.
But that doesn’t matter to governments, who permit countless suicide-pills in the form of mind-numbing anti-depressants and addictive opiates, yet can’t provide a single reason why you can’t have a mild new stimulant.
Like this Post? We have more on the way…
PricePlow is a price comparison site that asks one simple question: is this worth it?
The honest truth lives here. Follow us on social media below:
- Australian Government, Department of Health; “Scheduling delegate’s interim decisions and invitation for further comment: ACCS/ACMS, March 2017: 1.2. 1,3-Dimethylbutylamine (DMBA) and other aliphatic alkylamines including 1,5-dimethylhexylamine (DMHA)”; May 17, 2017; https://www.tga.gov.au/book-page/12-13-dimethylbutylamine-dmba-and-other-aliphatic-alkylamines-including-15-dimethylhexylamine-dmha (PDF copy)